Can acetylsalicylic acid (aspirin) cause placental abruption in pregnant women?

No, aspirin does not cause placental abruption in pregnancy

Low-dose aspirin (60-150 mg daily) does not increase the risk of placental abruption when used for preeclampsia prevention in pregnant women. The highest-quality guideline evidence demonstrates no significant increase in abruption risk, and this finding is consistent across multiple dosages and timing of initiation 1.

Evidence from Guidelines

The 2014 U.S. Preventive Services Task Force (USPSTF) recommendation provides the most authoritative guidance on this question. Their comprehensive meta-analysis of 11 randomized controlled trials involving 23,332 women found:

• No statistically significant increase in placental abruption with aspirin use (RR 1.17,95% CI 0.93-1.48) 1
• This finding held true regardless of aspirin dosage 1
• The USPSTF concluded with moderate certainty that low-dose aspirin harms are "no greater than small" 1

The guideline explicitly states: "Low-dose aspirin use in women at increased risk for preeclampsia has not been shown to increase the occurrence of placental abruption" 1.

Nuances in the Research Evidence

While guidelines provide reassurance, some recent research studies show conflicting signals that warrant discussion:

Studies Suggesting Possible Risk:

• A 2024 propensity-score matched study (71,627 pregnancies) found aspirin associated with increased abruption risk (aOR 1.44,95% CI 1.04-2.00), with a number needed to harm of 287 2
• A 2026 randomized trial comparing 162 mg vs 81 mg aspirin reported 8 cases of abruption in the 162 mg group versus 0 in the 81 mg group (p=0.013) 3

Studies Showing Protective or Neutral Effects:

• A 2018 meta-analysis found that aspirin ≥100 mg started ≤16 weeks may actually decrease abruption risk (RR 0.62,95% CI 0.31-1.26) compared to starting >16 weeks (RR 2.08) 4
• A 2019 Cochrane review (40,249 women, 77 trials) found aspirin probably marginally increases abruption, but the confidence interval included no effect (RR 1.21,95% CI 0.95-1.54) 5
• A 1995 meta-analysis of 11 trials found no increased risk of abruption with low-dose aspirin 6
• A 2020 meta-analysis showed no increase in abruption when aspirin started ≤16 weeks, though a trend toward increased risk when started >16 weeks 7

Clinical Algorithm for Decision-Making

When prescribing aspirin for preeclampsia prevention:

1. Dosage: Use 81-100 mg daily (standard U.S. formulation)

   • Higher doses (150-162 mg) may carry increased abruption risk based on limited data 3
   • The USPSTF found benefits consistent across 60-150 mg range 1

2. Timing: Initiate between 12-16 weeks gestation

   • Earlier initiation (≤16 weeks) appears safer regarding abruption risk 7, 4
   • Starting >16 weeks may have different risk profile 4

3. Risk Assessment: Prescribe for women with high-risk factors:

   • History of preeclampsia
   • Chronic hypertension
   • Pregestational diabetes
   • Renal disease
   • Autoimmune disease
   • Multifetal gestation 1

4. Monitoring: Be aware that absolute abruption risk remains low

   • Even if relative risk increases slightly, baseline incidence is 0.5-1%
   • Benefits (preventing preeclampsia, preterm birth, perinatal death) substantially outweigh potential harms 1

Important Caveats

The evidence quality differs between sources:

• The USPSTF guideline [1-1] represents the gold standard with moderate-to-high quality evidence from large randomized trials
• Recent observational studies 2 may reflect confounding by indication (sicker patients prescribed aspirin)
• The single RCT showing increased abruption 3 used higher doses (162 mg) than typically recommended

Common pitfall to avoid: Do not withhold aspirin from high-risk women due to abruption concerns. The substantial benefits in preventing preeclampsia (24% reduction), preterm birth (14% reduction), and perinatal death (15% reduction) far outweigh the uncertain and likely minimal increase in abruption risk 1, 5.

The FDA label 8 advises caution in the last 3 months of pregnancy but does not specifically contraindicate low-dose aspirin for preeclampsia prevention when medically indicated.